Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 16 , ISSUE 2 ( April-June, 2022 ) > List of Articles


Preeclampsia: Still a Disease of Theories

Edin Medjedović, Asim Kurjak, Milan Stanojevic, Aida Salihagic-Kadic

Keywords : Hypertension, Preeclampsia, Pregnancy

Citation Information : Medjedović E, Kurjak A, Stanojevic M, Salihagic-Kadic A. Preeclampsia: Still a Disease of Theories. Donald School J Ultrasound Obstet Gynecol 2022; 16 (2):138-147.

DOI: 10.5005/jp-journals-10009-1922

License: CC BY-NC 4.0

Published Online: 05-07-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Hypertensive disorders in pregnancy are responsible for more than 60,000 maternal deaths around the world each year, and cause complications in up to 12% of all pregnancies. Pregnancies complicated by preeclampsia show higher maternal and perinatal morbidity and mortality. Numerous theories exist attempting to explain the etiopathogenesis of preeclampsia. Preeclampsia may have early- or late-onset in pregnancy, with the same pathophysiology characterized by disturbed placental perfusion and endothelial dysfunction preceding the clinical manifestations. Causative therapy for preeclampsia is still missing, and the only effective therapy recognized so far is delivery, with expected recovery of pregnant women after 6 weeks. Early detection using general or specialized screening tests can reduce the consequences for health, especially in infants. This review has emphasized the multifactorial etiology of preeclampsia. Each of the cited etiological factors helps to elucidate the pathogenesis in some way—on the contrary, they also increase the need for the precise detection and understanding of the primary factors, which in most of the cases remain unknown. Therefore, based on the existing knowledge, preeclampsia may be considered as “disease of theories. ”The aim of the paper is to present the characteristics of pregnant women presenting with different types of preeclampsia, with an overview of the pathophysiological mechanism of the disease.

PDF Share
  1. Di Lorenzo G, Ceccarello M, Cecotti V, et al. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta 2012;33(6):495–501. DOI: 10.1016/j.placenta.2012.03.003
  2. Neto RM, Ramos JGL, Medjedovic E, et al. Increased of the carotid intima media thickness in preeclampsia. J Perinat Med 2020;48(8):787–791. DOI: 10.1515/jpm-2020-0158
  3. Impey L, Greenwood C, Sheil O, et al. The relation between pre-eclampsia at term and neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed 2001;85(3):F170–F172. DOI: 10.1136/fn.85.3.f170
  4. Medjedovic E, Suljevic A, Iglica A, et al. Uric acid values along with Doppler sonography findings as a tool for preeclampsia screening. Med Arch 2019;73(6):408–411. DOI: 10.5455/medarh.2019.73.408-411
  5. Fishel Bartal M, Sibai BM. Eclampsia in the 21st century. Am J Obstet Gynecol 2022;226(2S):S1237–S1253. DOI: 10.1016/j.ajog.2020.09.037
  6. Vukovic Babic M, Habek D, Habek Čerkez J. Perinatal epidemiological risk factors for preeclampsia. Acta Clin Croat 2015;54(1):9–13.
  7. Wright D, Wright A, Nicolaides KH. The competing risk approach for prediction of preeclampsia. Am J Obstet Gynecol 2020;223(1):12–23.e7. DOI: 10.1016/j.ajog.2019.11.1247
  8. Berhe AK, Kassa GM, Fekadu GA, et al. Prevalence of hypertensive disorders of pregnancy in Ethiopia: a systemic review and meta-analysis. BMC Pregnancy Childbirth 2018;18(1):34. DOI: 10.1186/s12884-018-1667-7
  9. Okby R, Harlev A, Sacks KN, et al. Preeclampsia acts differently in in vitro fertilization versus spontaneous twins. Arch Gynecol Obstet 2018;297(3):653–658. DOI: 10.1007/s00404-017-4635-y
  10. Healy AJ, Malone FD, Sullivan LM, et al. Early access to prenatal care: implications for racial disparity in perinatal mortality. Obstet Gynecol 2006;107(3):625–631. DOI: 10.1097/01.AOG.0000201978.83607.96
  11. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001;97(4):533–538. DOI: 10.1016/s0029-7844(00)01223-0
  12. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011;25(4):391–403. DOI: 10.1016/j.bpobgyn.2011.01.006
  13. Bell MJ. A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs 2010;39(5):510–518. DOI: 10.1111/j.1552-6909.2010.01172.x
  14. Kanasaki K, Kalluri R. The biology of preeclampsia. Kidney Int 2009;76(8):831–837. DOI: 10.1038/ki.2009.284
  15. American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122(5):1122–1131. DOI: 10.1097/01.AOG.0000437382.03963.88
  16. Staff AC. The two-stage placental model of preeclampsia: an update. J Reprod Immunol 2019;134-135:1-10. DOI: 10.1016/j.jri.2019.07.004
  17. Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and meta-analysis. Am J Obstet Gynecol 2008;198(1):7–22. DOI: 10.1016/j.ajog.2007.07.040
  18. Huang X, Wang J, Liu J, et al. Maternal periodontal disease and risk of preeclampsia: a meta-analysis. J Huazhong Univ Sci Technol Med Sci 2014;34(5):729–735. DOI: 10.1007/s11596-014-1343-8
  19. Kunnen A, van Doormaal JJ, Abbas F, et al. Periodontal disease and pre-eclampsia: a systematic review. J Clin Periodontol 2010;37(12):1075–1087. DOI: 10.1111/j.1600-051X.2010.01636.x
  20. Papageorghiou AT, Gunier RB, Villar J. The link between COVID-19 and preeclampsia. Am J Obstet Gynecol 2022;226(1): 153–154. DOI: 10.1016/j.ajog.2021.08.047
  21. Sathiya R, Rajendran J, Sumathi S. COVID-19 and preeclampsia: overlapping features in pregnancy. Rambam Maimonides Med J 2022;13(1):e0007. DOI: 10.5041/RMMJ.10464
  22. Conde-Agudelo A, Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol 2022;226(1):68–89.e3. DOI: 10.1016/j.ajog.2021.07.009
  23. Lee J, Ouh YT, Ahn KH, et al. Preeclampsia: a risk factor for gestational diabetes mellitus in subsequent pregnancy. PLoS One 2017;12(5):e0178150. DOI: 10.1371/journal.pone.0178150
  24. Schneider S, Freerksen N, Röhrig S, et al. Gestational diabetes and preeclampsia—similar risk factor profiles? Early Hum Dev 2012;88(3):179–184. DOI: 10.1016/j.earlhumdev.2011.08.004
  25. Nunes JS, Ladeiras R, Machado L, et al. The influence of preeclampsia, advanced maternal age and maternal obesity in neonatal outcomes among women with gestational diabetes. Rev Bras Ginecol Obstet 2020;42(10):607–613. DOI: 10.1055/s-0040-1710300
  26. Bicocca MJ, Mendez-Figueroa H, Chauhan SP, et al. Maternal obesity and the risk of early-onset and late-onset hypertensive disorders of pregnancy. Obstet Gynecol 2020;136(1):118–127. DOI: 10.1097/AOG.0000000000003901
  27. Smith GN, Pudwell J, Walker M, et al. Risk estimation of metabolic syndrome at one and three years after a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can 2012;34(9):836–841. DOI: 10.1016/S1701-2163(16)35382-8
  28. Hubel CA. Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol 1998;16(1):75–92. DOI: 10.1055/s-2007-1016255
  29. Jung E, Romero R, Yeo L, et al. The etiology of preeclampsia. Am J Obstet Gynecol 2022;226(2S):S844–S866. DOI: 10.1016/j.ajog.2021.11.1356
  30. Zilberman Sharon N, Maymon R, Melcer Y, et al. Obstetric outcomes of twin pregnancies presenting with a complete hydatidiform mole and coexistent normal fetus: a systematic review and meta-analysis. BJOG 2020;127(12):1450–1457. DOI: 10.1111/1471-0528.16283
  31. John AH, Duncan AS. The maternal syndrome associated with hydrops foetalis. J Obstet Gynaecol Br Commonw 1964;71:61–65. DOI: 10.1159/000305096
  32. Stepan H, Faber R. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med 2006;354(17): 1857–1858. DOI: 10.1056/NEJMc052721
  33. Tuohy JF, James DK. Pre-eclampsia and trisomy 13. Br J Obstet Gynaecol 1992;99(11):891–894. DOI: 10.1111/j.1471-0528.1992.tb14436.x
  34. Sarhanis P, Pugh DH. Resolution of pre eclampsia following intrauterine death of one twin. Br J Obstet Gynaecol 1992;99(2):159–160. DOI: 10.1111/j.1471-0528.1992.tb14478.x
  35. Bundhun PK, Soogund MZ, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001-2016. J Autoimmun 2017;79:17–27. DOI: 10.1016/j.jaut.2017.02.009
  36. Lee RM, Brown MA, Branch DW, et al. Anticardiolipin and anti-beta2- glycoprotein-I antibodies in preeclampsia. Obstet Gynecol 2003;102(2):294–300. DOI: 10.1016/s0029-7844(03)00477-0
  37. Wallukat G, Homuth V, Fischer T, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999;103(7):945–952. DOI: 10.1172/JCI4106
  38. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol 2006;6(8):584–594. DOI: 10.1038/nri1897
  39. Li DK, Wi S. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am J Epidemiol 2000;151(1):57–62. DOI: 10.1093/oxfordjournals.aje.a010122
  40. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005;5(10):807–817. DOI: 10.1038/nri1702
  41. Trowsdale J, Betz AG. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 2006;7(3):241–246. DOI: 10.1038/ni1317
  42. Okoror CEM, Enabudoso EJ, Okoror OT, et al. Serum calcium-magnesium ratio in women with pre-eclampsia at a tertiary hospital in Nigeria. Int J Gynaecol Obstet 2020;149(3):354–358. DOI: 10.1002/ijgo.13142
  43. Sánchez-Aranguren LC, Prada CE, Riaño-Medina CE, et al. Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol 2014;5:372. DOI: 10.3389/fphys.2014.00372
  44. Medjedovic E, Kurjak A. Doppler ultrasonography of the uterine artery in correlation with KANET. J Perinat Med 2020;49(4):455–459. DOI: 10.1515/jpm-2020-0544
  45. Baghlaf HA, Badeghiesh AM, Suarthana E, et al. The effect of Cushing's syndrome on pregnancy compli- cation rates: analysis of more than 9 million deliveries. J Matern Fetal Neonatal Med 2021;1–7. DOI: 10.1080/14767058.2021.1910658
  46. Hollenberg NK. Aldosterone in the development and progression of renal injury. Kidney Int 2004;66(1):1–9. DOI: 10.1111/j.1523-1755.2004.00701.x
  47. Lenders JWM, Langton K, Langenhuijsen JF, et al. Pheochromocytoma and pregnancy. Endocrinol Metab Clin North Am 2019;48(3):605–617. DOI: 10.1016/j.ecl.2019.05.006
  48. Kamari Y, Sharabi Y, Leiba A, et al. Peripartum hypertension from pheochromocytoma: a rare and challenging entity. Am J Hypertens 2005;18(10):1306–1312. DOI: 10.1016/j.amjhyper.2005.04.021
  49. Oliva R, Angelos P, Kaplan E, et al. Pheochromocytoma in pregnancy: a case series and review. Hypertension 2010;55(3): 600–606. DOI: 10.1161/HYPERTENSIONAHA.109.147579
  50. Rana S, Lemoine E, Granger JP, et al. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res 2019;124(7):1094–112. DOI: 10.1161/CIRCRESAHA.118.313276
  51. Whitley GS, Cartwright JE. Trophoblast-mediated spiral artery remodelling: a role for apoptosis. J Anat 2009;215(1): 21–26. DOI: 10.1111/j.1469-7580.2008.01039.x
  52. Saito S, Nakashima A. A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling. J Reprod Immunol 2014;101-102:80–88. DOI: 10.1016/j.jri.2013.06.002
  53. Stevenson GN, Noble JA, Welsh AW, et al. Automated visualization and quantification of spiral artery blood flow entering the first-trimester placenta, using 3-D power Doppler ultrasound. Ultrasound Med Biol 2018;44(3):522–531. DOI: 10.1016/j.ultrasmedbio.2017.11.018
  54. Zuniga AF, Ormazabal V, Gutierrez N, et al. Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsia. Biomed Res Int 2014;2014:353616. DOI: 10.1155/2014/353616
  55. Matijević R, Kos M, Kurjak A. Ultrazvuk i rano otkrivanje gestoza. U: Kurjak A, i sar. Ultrazvuk u ginekologiji i porodništvu. Zagreb: Art studio Azinović; 2000. p. 388–393.
  56. Woschitz MC, Idris T, Csapo B, et al. Uterine artery Doppler in women with history of previous pre eclampsia and women with chronic hypertension: re-evaluation of a prognostic value in a high-risk population. Gynecol Obstet (Sunnyvale) 2014;4(2):206. DOI: 10.4172/2161-0932.1000206
  57. Jurišić A, Jurisic Z, Pazin V, et al. Fetalni cerebralno-umbilikalni dopler odnos u predviđanju fetalnog distresa kod trudnica sa preeklampsijom. Vojnosanit Pregl 2010;67(6):487–492. DOI: 10.2298/vsp1006487j
  58. Wataganara T. Preeclamsia screening. In: Wataganara T, Pooh Kimata R, Kurjak A. Advanced Ultrasound in Obstetrics & Gynecology. New Delhi: The Health Sciences Publisher; 2015. 225.
  59. Leaños-Miranda A, Campos-Galicia I, Méndez-Aguilar F, et al. Lower circulating angiotensin II levels are related to the severity of preeclampsia and its risk as disclosed by a specific bioassay. Medicine (Baltimore) 2018;97(39):e12498. DOI: 10.1097/MD.0000000000012498
  60. Melchiorre K, Sharma R, Thilaganathan B. Cardiovascular implications in preeclampsia: an overview. Circulation 2014;130(8):703–714. DOI: 10.1161/CIRCULATIONAHA.113.003664
  61. Lavie A, Ram M, Lev S, et al. Maternal cardiovascular hemodynamics in normotensive versus preeclamptic pregnancies: a prospective longitudinal study using a noninvasive cardiac system (NICaS™). BMC Pregnancy Childbirth 2018;18(1):229. DOI: 10.1186/s12884-018-1861-7
  62. Roubalová L, Vojtěch J, Feyereisl J, et al. First-trimester screening for preeclampsia. Ceska Gynekol 2019;84(5): 361–370.
  63. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol 2012;36(1):56–59. DOI: 10.1053/j.semperi.2011.09.011
  64. Skjaerven R, Wilcox AJ, Klungsøyr K, et al. Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ 2012;345:e7677. DOI: 10.1136/bmj.e7677
  65. ACOG Committee on Obstetric Practice. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002;99(1):159–167. DOI: 10.1016/s0029-7844(01)01747-1
  66. Porto LB, Brandão AHF, Leite HV, et al. Longitudinal evaluation of uterine perfusion, endothelial function and central blood flow in early onset pre-eclampsia. Pregnancy Hypertens 2017;10:161–164. DOI: 10.1016/j.preghy.2017.08.005
  67. Magee LA, Pels A, Helewa M. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014;36(5): 416–438. DOI: 10.1016/s1701-2163(15)30588-0
  68. Al-Amin A, Rolnik DL, Black C, et al. Accuracy of second trimester prediction of preterm preeclampsia by three different screening algorithms. Aust N Z J Obstet Gynaecol 2018;58(2):192–196. DOI: 10.1111/ajo.12689
  69. Medjedovic E, Suljevic A, Iglica A, et al. Doppler sonography of uterine arteries in pregnancy as a marker of preeclampsia. Donald School J Ultrasound Obstet Gynecol 2019;13(4): 162–168. DOI: 10.5005/jp-journals-10009-1611
  70. Napolitano R, Melchiorre K, Arcangeli T, et al. Screening for pre-eclampsia by using changes in uterine artery Doppler indices with advancing gestation. Prenat Diagn 2012;32(2):180–184. DOI: 10.1002/pd.2930
  71. Schuman H, Ducey J, Farmakides G. Uterine artery Doppler velocimetry. The significance of divergent systolic-diastolic ratios. Obstet Gynecol 2007;59:1072–1076. DOI: 10.1016/s0002-9378(87)80259-4
  72. Medjedovic E, Kurjak A. The importance of Doppler analysis of uterine circulation in pregnancy for a better understanding of preeclampsia. Med Arch 2021;75(6):424–430. DOI: 10.5455/medarh.2021.75.424-430
  73. Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008;178(6):701–711. DOI: 10.1503/cmaj.070430
  74. Medjedovic E. The influence of blood flow in uterine arteries measured by Doppler on fetal behavior in preeclampsia. PhD thesis. Sarajevo: Sarajevo School of Science and Technology; 2021.
  75. Vukovic-Bobic M, Habek D. Biljezi rane detekcije preeklampsije. Gynaecol Perinatol 2013;22(1):1–8.
  76. Delic R. Statistički regresijski model standardnih i novih laboratorijskih pokazatelja u predviđanju preeklampsija. Doktorski rad. Zagreb: Sveučilište u Zagrebu. Prirodoslovno matematički fakultet. Biološki odsjek; 2012. 107.
  77. Lagana AS, Favilli A, Triolo O, et al. Early serum markers of pre-eclampsia: are we stepping forward? J Matern Fetal Neonatal Med 2016;29(18):3019–3023. DOI: 10.3109/14767058.2015.1113522
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.